The specter of glycopeptide resistance: current trends and future considerations
- 1 May 1998
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 104 (5) , 3S-6S
- https://doi.org/10.1016/s0002-9343(98)00148-x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Vancomycin‐Resistant EnterococciClinical Infectious Diseases, 1998
- VanD-type glycopeptide-resistant Enterococcus faecium BM4339Antimicrobial Agents and Chemotherapy, 1997
- Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1997
- Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibilityJournal of Antimicrobial Chemotherapy, 1997
- The effect of vancomycin on the structure of vancomycin-susceptible and -resistant Enterococcus faecium strainsAntimicrobial Agents and Chemotherapy, 1997
- Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureusJournal of Bacteriology, 1997
- Resistance to Glycopeptides in EnterococciClinical Infectious Diseases, 1997
- Current perspectives on glycopeptide resistance.Clinical Microbiology Reviews, 1995
- Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in manJournal of Antimicrobial Chemotherapy, 1994
- Structure, biochemistry and mechanism of action of glycopeptide antibioticsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989